Clear Cut Medical

www.clrcut.com

ClearCut Medical was established to develop and commercialize its proprietary technology and tools for accurate and effective removal of cancer. ClearCut’s platform technology is based on an innovative new form factor for the use of Magnetic Resonance (MRI) that enables accurate and rapid surface imaging for real-time assessment of tissue microstructure in the operating room. The company’s first product, The ClearSightTM MRI System is focused on breast cancer lumpectomy for intraoperative margin assessment of surgically removed tumors. By providing accurate, real-time and simple margin analysis to the surgeon in the OR, the system is able to significantly improve surgical outcomes and reduce re-excision rates. To date over 400 patients have participated in international, multi-center clinical trials, which have shown excellent accuracy compared to the gold standard final histopathology and the potential to reduce the re-excision rates in breast conserving surgery by 80%. Future applications include other surgical excisions of cancerous tumors and biopsies throughout the body.

Read more

Reach decision makers at Clear Cut Medical

Lusha Magic

Free credit every month!

ClearCut Medical was established to develop and commercialize its proprietary technology and tools for accurate and effective removal of cancer. ClearCut’s platform technology is based on an innovative new form factor for the use of Magnetic Resonance (MRI) that enables accurate and rapid surface imaging for real-time assessment of tissue microstructure in the operating room. The company’s first product, The ClearSightTM MRI System is focused on breast cancer lumpectomy for intraoperative margin assessment of surgically removed tumors. By providing accurate, real-time and simple margin analysis to the surgeon in the OR, the system is able to significantly improve surgical outcomes and reduce re-excision rates. To date over 400 patients have participated in international, multi-center clinical trials, which have shown excellent accuracy compared to the gold standard final histopathology and the potential to reduce the re-excision rates in breast conserving surgery by 80%. Future applications include other surgical excisions of cancerous tumors and biopsies throughout the body.

Read more
icon

Country

icon

City (Headquarters)

Reẖovot

icon

Employees

11-50

icon

Founded

2011

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Investor

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(1)

Reach decision makers at Clear Cut Medical

Free credits every month!

My account

Sign up now to uncover all the contact details